Wire Stories
Shionogi Advances Ensitrelvir Fumaric Acid COVID-19 Antiviral Clinical Program
OSAKA, Japan–(BUSINESS WIRE)–Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) today announced progress on...